Norwich, VT – 25 September 2024 – Cure Blindness Project, a leading non-profit dedicated to eliminating avoidable blindness around the world, is excited to announce the launch of its new bi-annual newsletter, Cure Blindness Project MD Newsletter. This valuable resource will provide medical professionals, and anyone interested in eye health advancements, with in-depth insights into groundbreaking innovations shaping global ophthalmology.
“The MD Newsletter is a valuable tool for staying informed about the latest advancements being made by Cure Blindness Project and its partners in global ophthalmology,” says K-T Overbey, CEO, Cure Blindness Project. “By sharing inspiring success stories, groundbreaking research, and transformative training initiatives, we hope to empower healthcare professionals around the world to make a lasting impact on patient outcomes.”
The Cure Blindness Project MD Newsletter offers a comprehensive overview of the latest procedures, treatments, and research led by Cure Blindness Project and its partners. Articles are written by leading experts, giving readers an exclusive look at how the fight against blindness is progressing across sub-Saharan Africa and South Asia.
Subscribe now: https://cureblindness.org/md-newsletter.
Success Stories from the Field
Investing in the Future
Join the Community
Together, We Can Cure Avoidable Blindness
Cure Blindness Project is a global leader in ophthalmology, having performed over 1.6 million sight-restoring surgeries worldwide. By empowering local healthcare systems with the knowledge, skills, and resources they need to deliver high-quality eye care, the project is working towards a future where everyone can see clearly.
###
Founded as Himalayan Cataract Project, Cure Blindness Project today celebrates 30 years of restoring sight. This singular mission expanded from its origins in Nepal to 30 countries with high-quality eye care, education, and world-class eye care infrastructure. Together with partners, Cure Blindness Project has provided over 1.6 million sight-restoring surgeries and provided screening and basic care to over 16.5 million people.